HDAC1 overexpression enhances β-cell proliferation by down-regulating Cdkn1b/p27

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• Nkx6.1 transcription factor is known to increase functional beta-cell mass, encompassing proliferation, insulin secretion, and survival.
• Understanding the molecular mechanisms downstream of Nkx6.1 is crucial for developing strategies to enhance beta-cell function.

Purpose of the Study:

• To investigate the role of histone deacetylase 1 (HDAC1) as an early target of Nkx6.1 in regulating functional beta-cell mass.
• To determine if HDAC1 activity is sufficient to increase beta-cell proliferation and survival while maintaining glucose-stimulated insulin secretion (GSIS).

Main Methods:

• Utilized primary rat islets and INS-1 832/13 beta-cell line for experiments.
• Assessed beta-cell proliferation, GSIS, and cell survival under various conditions.
• Analyzed the expression levels of cell cycle regulators, including Cdkn1b/p27, Cyclin A2, Cyclin B1, and E2F1.

Main Results:

• HDAC1 overexpression was sufficient to increase beta-cell proliferation in both primary islets and cell lines.
• HDAC1-mediated proliferation occurred without compromising GSIS and enhanced beta-cell survival.
• HDAC1 overexpression decreased Cdkn1b/p27 expression, leading to increased expression of cell cycle activators (Cyclin A2, Cyclin B1, E2F1).
• Overexpression of Cdkn1b/p27 inhibited HDAC1-mediated beta-cell proliferation.

Conclusions:

• HDAC1 is a key mediator in the Nkx6.1 pathway for enhancing functional beta-cell mass.
• HDAC1 promotes beta-cell proliferation by down-regulating the cell cycle inhibitor Cdkn1b/p27.
• HDAC1 represents a potential therapeutic target for increasing beta-cell mass in conditions like diabetes.